Clinical Trial

Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 11, 2025 (before its estimated December 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
Mycobacterium leprae is a slow-growing bacillus that causes leprosy. the infection may take two to ten years to incubate. While the exact mechanism of infection transmission is unknown, direct bacillus absorption through the nasal or respiratory mucosa and aerosolized nasal secretions are the most common theories. The bacteria is subsequently transported by the bloodstream to the peripheral nerves, where it can result in tissue damage from painless burns and ulcers as well as irreparable nerve damage that results in a loss of protective feeling.
Trial Details
NCT Number NCT06819449
Lead Sponsor South Valley University
Conditions Leprosy, Mycobacterium Leprae Infection
Enrollment 50 participants
Start Date 2024-12-20
Primary Completion 2025-12-10 (estimated)
Study Completion 2025-12-20 (estimated)
Updated on ClinicalTrials.gov 2025-02-11